Preloader Close
#ISAD2023

Hall A - Aula Magna

Home / Scientific Information » Scientific Programme » Hall A - Aula Magna

Scientific Information

Hall A
Aula Magna
08:55-09:00

Welcome back
09:00-10:30  

Symposium 2
Treatment-resistant depression: Best practice and beyond
Chair: Anthony Cleare, King's College London, UK
Latest evidence on pharmacological augmentation for treatment-resistant depression:
Does the Lithium versus Quetiapine (LQD) Study change best practice?
Anthony Cleare, King's College London, UK
The genetics of treatment-resistant depression:
Results and new opportunities from biobanks and electronic health records
Chiara Fabbri, University of Bologna, Italy
Ketamine and esketamine for unipolar and bipolar depression
Philipp Ritter, University Hospital Carl Gustav Carus Dresden, Germany
The role of probiotic supplementation in Major Depressive Disorder and TRD
Viktoriya Nikolova, King's College London, UK
10:30-11:15

Coffee Break & Poster Session A 
P-001 to P-030
11:15-12:00

Plenary Session 1
The Rational for Subtyping Depression in Research and Clinical Settings
Martin Preisig, Lausanne University Hospital Center, Switzerland
12:00-13:00

Industry Session 1

13:00-14:00

Lunch Break and Exhibition
14:00-15:30

Symposium 4
Defining developmental trajectories of anxiety and depression throughout the lifespan:
Risk factors and targets for prevention and treatment programs
Chair: Paolo Brambilla, University of Milan, Italy
The vulnerability stress model and longitudinal brain structure:
Interaction of early and current environmental stress in affective disorders
Tilo Kircher, University of Marburg, Germany
Course prediction of depression and anxiety disorders in the NESDA project
Brenda Penninx, Amsterdam UMC, The Netherlands
Longitudinal neonatal brain development and environmental
correlates of infant outcomes following preterm birth
Chiara Nosarti, King's College London, UK
Internalizing symptoms trajectories from childhood to early adulthood, through adolescence, in clinical and general population samples: Results from the REMIND project
Maria Nobile, Scientific Institute IRCCS 'E. Medea', Italy
15:30-17:00

Short Oral Presentations Session 1
Chair: Anthony Cleare, King's College London, UK
 15:30 - 15:45

O-01
Repetitive Transcranial Magnetic Stimulation: standard vs accelerated protocol’s efficacy on depressive core symptoms
Valentina Fazio, Vita-Salute San Raffaele University, Italy
 15:45 - 16:00

O-02
Do psychometrics matter? The effects of advanced psychometrics on antidepressant randomised trial outcomes
Frank Doyle, RCSI University of Medicine and Health Sciences, Ireland
 16:00 - 16:15

O-03
REDUCE (REviewing long term antiDepressant use by Careful monitoring in Everyday practice): randomised controlled trial
Tony Kendrick, University of Southampton, UK
 16:15 - 16:30

O-04 (Early Career Award Winner)
Could low-dose lithium be a viable neuroprotective supplement?
Rebecca Strawbridge, King's College London, UK
 16:30 - 16:45

O-05 (Early Career Award Winner)
Is there a biological link between bipolar disorder and frontotemporal dementia? A neuroimaging perspective
Giuseppe Del Vecchio, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Italy
16:45 - 17:00 

O-06 (Patient Advocate Award Winner)
Hormones and hypersexuality: Challenges facing women with bipolar
Clare Dolman, King's College London, UK
17:00-17:45

Coffee Break & Poster Session B
P-031 to P-060